Literature DB >> 35450171

Preoperative laser reduces silicone oil use in primary diabetic vitrectomy.

Wen-Bin Zheng1, Xiao-Hu Ding1, Kun-Bei Lai1, Ji-Zhu Li1, Yu-Qing Wu1, Yuan Ma1, Zi-Ye Chen1, Shi-Da Chen1, Sai-Nan Xiao1, Bing-Qian Liu1, Ying Lin1, Tao Li1.   

Abstract

AIM: To identify the predictive factors and laser photocoagulation associated with the use of silicone oil as endotamponade during primary diabetic vitrectomy.
METHODS: The medical and surgical records of 690 patients (798 eyes) who underwent primary diabetic vitrectomy at a tertiary eye hospital in China from January 2018 to December 2018 were reviewed in this retrospective cohort study. The patients' baseline characteristics and preoperative treatments were recorded. The binary Logistic regression model was used to evaluate the risk factors for the use of silicone oil as endotamponade agent during primary vitrectomy for proliferative diabetic retinopathy (PDR)-related complications.
RESULTS: Among 690 patients with mean age of 52.1±10.5y (range: 18-85y), 299/690 (43.3%) were female. The 31.6% of the eyes received preoperative laser treatment, and 72.4% of the eyes received preoperative anti-VEGF adjuvant therapy. Non-clearing vitreous haemorrhage (VH) alone or combined with retinal detachment was the main surgical indication (89.5%) for primary vitrectomy. Silicone oil was used as endotamponade in 313 (39.2%) eyes. Lack of preoperative laser treatment [odds ratio (OR) 0.66, 95% confidence interval (CI): 0.48-0.92; P=0.015] and older age (OR 0.96, 95%CI: 0.95-0.98; P<0.001) were predictors of silicone oil tamponade during primary vitrectomy for PDR.
CONCLUSION: The lack of preoperative laser treatment is a significant predictor of silicone oil tamponade during primary vitrectomy for PDR. However, the severity of PDR relevant to silicone oil use should be further evaluated. International Journal of Ophthalmology Press.

Entities:  

Keywords:  laser photocoagulation; predictive factors; proliferative diabetic retinopathy; silicone oil tamponade; vitrectomy

Year:  2022        PMID: 35450171      PMCID: PMC8995724          DOI: 10.18240/ijo.2022.04.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  32 in total

1.  Vitrectomy with silicone oil infusion in severe diabetic retinopathy.

Authors:  A Castellarin; R Grigorian; N Bhagat; L Del Priore; M A Zarbin
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

Authors:  Eric Chen; Carl H Park
Journal:  Retina       Date:  2006 Jul-Aug       Impact factor: 4.256

3.  Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months.

Authors:  George Morphis; Cristina Irigoyen; Antonio Eleuteri; Theodor Stappler; Ian Pearce; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-04       Impact factor: 3.117

5.  Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-11

6.  Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.

Authors:  Christoffer Ostri; Anja Lux; Henrik Lund-Andersen; Morten la Cour
Journal:  Acta Ophthalmol       Date:  2013-12-23       Impact factor: 3.761

7.  Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors:  Andrew N Antoszyk; Adam R Glassman; Wesley T Beaulieu; Lee M Jampol; Chirag D Jhaveri; Omar S Punjabi; Hani Salehi-Had; John A Wells; Maureen G Maguire; Cynthia R Stockdale; Daniel F Martin; Jennifer K Sun
Journal:  JAMA       Date:  2020-12-15       Impact factor: 56.272

Review 8.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

9.  Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy.

Authors:  Alireza Ramezani; Hamid Ahmadieh; Amin Rozegar; Masoud Soheilian; Morteza Entezari; Siamak Moradian; Mohammad H Dehghan; Homayoun Nikkhah; Mehdi Yaseri
Journal:  Korean J Ophthalmol       Date:  2017-05-12

Review 10.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.